Skip to main content
ENDO 2026 Main banner

Topic: General Endocrinology
Session Type: Plenary

PL04 - Post-Plenary Discussion: Metabolism in Motion: Endocrine Regulation as a Launchpad for Therapeutic Innovation

Sunday, June 14, 2026
9:30 AM - 10:15 AM CT
Location: ENDOExpo; ENDO Booth

    Moderator(s)

  • EN

    Erik Nelson, PhD

    Professor
    Molecular and Integrative Physiology
    University of Illinois at Urbana-Champaign
    Urbana, Illinois, United States

    Disclosure information not submitted.

    • Plenary Speaker(s)

  • SK

    Steven Kliewer, PhD

    Professor
    Department of Molecular Biology
    University of Texas Southwestern Medical Center
    Dallas, Texas, United States

    Disclosure(s): Atias Pharmaceuticals: Advisory Board (), Owner/Co-Owner Founder/Co-Founder ()

  • Donald McDonnell, PhD

    Professor
    Duke University School of Medicine
    Durham, NC, United States

    Disclosure(s): Adara Pharmaceuticals: Owner/Co-Owner Founder/Co-Founder (); Bristol Myers Squibb: Consultant (), Grant Recipient (); Coregen: Advisory Board (); Daichi Sankyo: Consultant (); Foghorn Therapeutics: Consultant (); Interdict Bio: Advisory Board (); Menarini: Grant Recipient (), Intellectual property (); Pappas Capital: Advisory Board (); Parabilis Medicine: Consultant (); Precede Therapeutics: Consultant (), Grant Recipient (); Rappta Pharmaceuticals: Advisory Board (); Stemline: Consultant ()

Disclosure(s):
Steven Kliewer, PhD: Atias Pharmaceuticals: Advisory Board (), Owner/Co-Owner Founder/Co-Founder ()
Donald McDonnell, PhD: Adara Pharmaceuticals: Owner/Co-Owner Founder/Co-Founder (); Bristol Myers Squibb: Consultant (), Grant Recipient (); Coregen: Advisory Board (); Daichi Sankyo: Consultant (); Foghorn Therapeutics: Consultant (); Interdict Bio: Advisory Board (); Menarini: Grant Recipient (), Intellectual property (); Pappas Capital: Advisory Board (); Parabilis Medicine: Consultant (); Precede Therapeutics: Consultant (), Grant Recipient (); Rappta Pharmaceuticals: Advisory Board (); Stemline: Consultant ()

Following each plenary session, join a dynamic conversation with the speakers led by esteemed Endocrine Society members. This interactive session offers a unique opportunity to delve deeper into the cutting-edge research and clinical practice presented.


Ask questions, challenge assumptions, and engage in a lively exchange of ideas with the experts. Gain fresh perspectives and explore the future of research, discovery, and patient care.